TransOcean Capital

Description

TransOcean Group, Ltd. is a private equity firm seeking majority investments in U.S.-based companies demonstrating strong and sustainable cash flows and having the following characteristics: Enterprise values between $100 million and $200 million. Niche leadership or market leadership position Participant in traditional industry sectors—these may include industrial manufacturing, branded food products, healthcare services and medical devices Proven management team Well-defined growth strategy Consistent ability to generate strong EBITDA We transact at full market value and generally take on less leverage than competing private equity firms.

TransOcean Capital is a Boston-based private equity firm targeting majority control investments in US companies with $100M–$200M enterprise values across traditional sectors including healthcare services and medical devices. No confirmed dental holdings, but the explicit healthcare-services mandate makes them a plausible dental-platform acquirer.

TransOcean Capital's own LinkedIn description explicitly lists 'healthcare services and medical devices' among its target sectors for majority buyouts of US companies with $100M–$200M enterprise values, meeting the pe_sponsor threshold as a credible platform acquirer in healthcare services.

enriched 2026-05-05

Financials